Search - tctmd.com

Displaying 121 - 140 of 323

Sort: Relevancy | Date

Presentation THT 2024

Catheter Directed Lytics as the Primary Option

Presenter: Adnan Khalif

March 06, 2024

Presentation THT 2024

Catheter Thrombectomy as the Primary Option

Presenter: Kenneth Rosenfield

March 06, 2024

Presentation THT 2024

Case Presentation

Presenter: Sareena George

March 06, 2024

Presentation THT 2024

Risk Stratification and Treatment Goals of Acute PE

Presenter: Catalin Toma

March 06, 2024

Presentation THT Abstracts 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presenter: Daniel Snyder

March 05, 2024

Presentation THT Abstracts 2024

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Presenter: Robert Zilinyi

March 04, 2024

Presentation THT Abstracts 2024

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Presenter: Robert Zilinyi

March 04, 2024

Presentation TCT 2023

Case 3: High Risk Intermediate PE With Iliocaval DVT

Presenter: Sonal Pruthi

October 26, 2023

Presentation TCT 2023

Case 2: Neurosurgical Patient With High Risk Intermediate PE

Presenter: Sameer Khandhar

October 26, 2023

Presentation TCT 2023

Case 1: Massive PE With Shock

Presenter: Peter Monteleone

October 26, 2023

Presentation TCT 2023

TCT 547: Pulmonary Artery Pressure Reduction With Mechanical Thrombectomy for Pulmonary Embolism Predicts Improved Patient Outcomes Within 48 Hours: Results From the FLASH Registry US Cohort

Presenter: Catalin Toma

October 25, 2023

Presentation TCT 2023

CAT RX Technology Product Overview and Case Presentations

Presenter: Sahil Parikh

October 25, 2023

Presentation TCT 2023

Clinical Trial Evidence Update

Presenter: Suhail Dohad

October 25, 2023

Presentation TCT 2023

FLASH Technology Product Overview & Case Presentations

Presenter: S. Jay Mathews

October 25, 2023

Presentation TCT 2023

Patient Selection and When to Treat

Presenter: Andrew Sharp

October 25, 2023

Presentation TCT 2023

Other Diseases/Entities Treated With PE-Related Technologies: Masses

Presenter: James McCabe

October 25, 2023

Presentation TCT 2023

Other Diseases/Entities Treated With PE-Related Technologies: Vegetations

Presenter: Abdallah El Sabbagh

October 25, 2023

Presentation TCT 2023

State of the Art Lecture: New Devices and Catheters: What Will Be New in 2024?

Presenter: Robert Lookstein

October 25, 2023

Presentation TCT 2023

Clinical Trial Update

Presenter: Akhilesh Sista

October 25, 2023

Presentation TCT 2023

Modeling the RV Through HARVI

Presenter: Sanjum Sethi

October 25, 2023

Advertisement

Catheter Directed Lytics as the Primary Option

Catheter Thrombectomy as the Primary Option

Case Presentation

Risk Stratification and Treatment Goals of Acute PE

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Clinical Presentation, Management, and Outcomes of Patients with Intermediate Risk Acute Pulmonary Embolism and Normotensive Shock.

Case 3: High Risk Intermediate PE With Iliocaval DVT

Case 2: Neurosurgical Patient With High Risk Intermediate PE

Case 1: Massive PE With Shock

TCT 547: Pulmonary Artery Pressure Reduction With Mechanical Thrombectomy for Pulmonary Embolism Predicts Improved Patient Outcomes Within 48 Hours: Results From the FLASH Registry US Cohort

CAT RX Technology Product Overview and Case Presentations

Clinical Trial Evidence Update

FLASH Technology Product Overview & Case Presentations

Patient Selection and When to Treat

Other Diseases/Entities Treated With PE-Related Technologies: Masses

Other Diseases/Entities Treated With PE-Related Technologies: Vegetations

State of the Art Lecture: New Devices and Catheters: What Will Be New in 2024?

Clinical Trial Update

Modeling the RV Through HARVI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content